Frequent and long-term follow-up of health-related quality of life following allogeneic haematopoietic stem cell transplantation.
(2015) In European Journal of Cancer Care 24(6). p.898-910- Abstract
- Health-related quality of life (HRQL) was evaluated in 94 patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT) after myeloablative (MAC, n = 18) or reduced intensity conditioning (RIC, n = 76). HRQL was assessed with the EORTC QLQ C-30 during the inpatient period as well as during the following 3 years, i.e. at baseline and 12 times thereafter. Functional status and global quality of life decreased from baseline to weeks 2 and 3, especially role and social functions. Symptoms increased significantly during the first 3 weeks, particularly appetite loss, nausea and vomiting, diarrhoea and fatigue. It took at least 1 year for HRQL to return to the baseline level. The only function that improved significantly 3 years... (More)
- Health-related quality of life (HRQL) was evaluated in 94 patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT) after myeloablative (MAC, n = 18) or reduced intensity conditioning (RIC, n = 76). HRQL was assessed with the EORTC QLQ C-30 during the inpatient period as well as during the following 3 years, i.e. at baseline and 12 times thereafter. Functional status and global quality of life decreased from baseline to weeks 2 and 3, especially role and social functions. Symptoms increased significantly during the first 3 weeks, particularly appetite loss, nausea and vomiting, diarrhoea and fatigue. It took at least 1 year for HRQL to return to the baseline level. The only function that improved significantly 3 years after HSCT was role function. Patients treated with MAC experienced significantly worse HRQL at baseline than patients treated with RIC, as well as more pain, sleep disturbance and appetite loss in weeks 3 and 4. Patients with extensive chronic graft-versus-host disease experienced reduced HRQL. These results provide a clinically useful overview of patients' HRQL during and after HSCT and indicate when they require increased support. The results demonstrate the importance of close follow-ups during the first year after HSCT to improve preventive or supportive interventions. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/7745646
- author
- Frödin, U ; Lotfi, K ; Fomichov, V ; Juliusson, Gunnar LU and Börjeson, S
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Journal of Cancer Care
- volume
- 24
- issue
- 6
- pages
- 898 - 910
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- pmid:26156141
- wos:000363466200014
- scopus:84945445189
- pmid:26156141
- ISSN
- 1365-2354
- DOI
- 10.1111/ecc.12350
- language
- English
- LU publication?
- yes
- id
- 851861f6-8ab2-406f-b296-09c6b61b3e1d (old id 7745646)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26156141?dopt=Abstract
- date added to LUP
- 2016-04-01 10:25:57
- date last changed
- 2022-08-05 06:52:39
@article{851861f6-8ab2-406f-b296-09c6b61b3e1d,
abstract = {{Health-related quality of life (HRQL) was evaluated in 94 patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT) after myeloablative (MAC, n = 18) or reduced intensity conditioning (RIC, n = 76). HRQL was assessed with the EORTC QLQ C-30 during the inpatient period as well as during the following 3 years, i.e. at baseline and 12 times thereafter. Functional status and global quality of life decreased from baseline to weeks 2 and 3, especially role and social functions. Symptoms increased significantly during the first 3 weeks, particularly appetite loss, nausea and vomiting, diarrhoea and fatigue. It took at least 1 year for HRQL to return to the baseline level. The only function that improved significantly 3 years after HSCT was role function. Patients treated with MAC experienced significantly worse HRQL at baseline than patients treated with RIC, as well as more pain, sleep disturbance and appetite loss in weeks 3 and 4. Patients with extensive chronic graft-versus-host disease experienced reduced HRQL. These results provide a clinically useful overview of patients' HRQL during and after HSCT and indicate when they require increased support. The results demonstrate the importance of close follow-ups during the first year after HSCT to improve preventive or supportive interventions.}},
author = {{Frödin, U and Lotfi, K and Fomichov, V and Juliusson, Gunnar and Börjeson, S}},
issn = {{1365-2354}},
language = {{eng}},
number = {{6}},
pages = {{898--910}},
publisher = {{John Wiley & Sons Inc.}},
series = {{European Journal of Cancer Care}},
title = {{Frequent and long-term follow-up of health-related quality of life following allogeneic haematopoietic stem cell transplantation.}},
url = {{http://dx.doi.org/10.1111/ecc.12350}},
doi = {{10.1111/ecc.12350}},
volume = {{24}},
year = {{2015}},
}